Management of obstructive sleep apnea in Europe

I Fietze; T Penzel; A Alonderis; F Barbe; M R Bonsignore; P Calverly; W De Backer; K Diefenbach; V Donic; M M Eijsvogel; K A Franklin; T Gislason; L Grote; J Hedner; Poul Jørgen Jennum; L Lavie; P Lavie; Paul Levy; C Lombardi; W Mallin; O Marrone; Montserrat Anguita; E S Papathanasiou; G Parati; R Plywaczewski; M Pretl; R L Riha; D Rodenstein; T Saaresranta; R Schulz; P Sliwinski; P Steiropoulos; J Svaza; Z Tomori; Philip Tønnesen; G Varoneckas; J Verbraecken; J Vesely; A Vitols; J Zielinski; W T McNicholas; COST Action B26 Group

doi:10.1016/j.sleep.2010.10.003

Management of obstructive sleep apnea in Europe

I Fietze, T Penzel, A Alonderis, F Barbe, M R Bonsignore, P Calverly, W De Backer, K Diefenbach, V Donic, M M Eijsvogel, K A Franklin, T Gislason, L Grote, J Hedner, Poul Jørgen Jennum, L Lavie, P Lavie, Paul Levy, C Lombardi, W MallinO Marrone, Montserrat Anguita, E S Papathanasiou, G Parati, R Plywaczewski, M Pretl, R L Riha, D Rodenstein, T Saaresranta, R Schulz, P Sliwinski, P Steiropoulos, J Svaza, Z Tomori, Philip Tønnesen, G Varoneckas, J Verbraecken, J Vesely, A Vitols, J Zielinski, W T McNicholas, COST Action B26 Group

ICMM Teaching

41 Citationer (Scopus)

Abstract

Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services. Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example. Results: Sleep centers from 21 countries (38 physicians) participated. A broad consistency among countries with respect to the following was found: pathways included referral to sleep physicians/sleep laboratories, necessity for objective diagnosis (primarily by polysomnography), use of polygraphic methods, analysis of polysomnography (PSG), indications for positive airway pressure (PAP) therapy, application of standard continuous PAP (CPAP) therapy (100% with an CPAP/APAP ratio of 2.24:1), and the need (90.5%) and management of follow-up. Differences were apparent in reimbursement of the diagnostic procedures and follow-up, in the procedures for PAP titration from home APAP titration with portable sleep apnea monitoring (38.1%) up to hospital monitoring with PSG and APAP (85.7%), and in the qualification requirements of sleep physicians. Conclusions: Management of OSA in different European countries is similar except for reimbursement rules, qualification of sleep specialists and procedures for titration of the CPAP treatment. A European network (such as the one accomplished by the European Cooperation in Science and Technology [COST] B26 Action) could be helpful for implementing these findings into health-service research in order to standardize management in a cost effective perspective.

Originalsprog	Engelsk
Tidsskrift	Sleep Medicine
Vol/bind	12
Udgave nummer	2
Sider (fra-til)	190-7
Antal sider	8
ISSN	1389-9457
DOI	https://doi.org/10.1016/j.sleep.2010.10.003
Status	Udgivet - 1 feb. 2011

Adgang til dokumentet

10.1016/j.sleep.2010.10.003

Citationsformater

Fietze, I., Penzel, T., Alonderis, A., Barbe, F., Bonsignore, M. R., Calverly, P., De Backer, W., Diefenbach, K., Donic, V., Eijsvogel, M. M., Franklin, K. A., Gislason, T., Grote, L., Hedner, J., Jennum, P. J., Lavie, L., Lavie, P., Levy, P., Lombardi, C., ... COST Action B26 Group (2011). Management of obstructive sleep apnea in Europe. Sleep Medicine, 12(2), 190-7. https://doi.org/10.1016/j.sleep.2010.10.003

Fietze, I, Penzel, T, Alonderis, A, Barbe, F, Bonsignore, MR, Calverly, P, De Backer, W, Diefenbach, K, Donic, V, Eijsvogel, MM, Franklin, KA, Gislason, T, Grote, L, Hedner, J, Jennum, PJ, Lavie, L, Lavie, P, Levy, P, Lombardi, C, Mallin, W, Marrone, O, Anguita, M, Papathanasiou, ES, Parati, G, Plywaczewski, R, Pretl, M, Riha, RL, Rodenstein, D, Saaresranta, T, Schulz, R, Sliwinski, P, Steiropoulos, P, Svaza, J, Tomori, Z, Tønnesen, P, Varoneckas, G, Verbraecken, J, Vesely, J, Vitols, A, Zielinski, J, McNicholas, WT & COST Action B26 Group 2011, 'Management of obstructive sleep apnea in Europe', Sleep Medicine, bind 12, nr. 2, s. 190-7. https://doi.org/10.1016/j.sleep.2010.10.003

@article{f76c51320788405583fecd11b4094acb,

title = "Management of obstructive sleep apnea in Europe",

abstract = "Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services. Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example. Results: Sleep centers from 21 countries (38 physicians) participated. A broad consistency among countries with respect to the following was found: pathways included referral to sleep physicians/sleep laboratories, necessity for objective diagnosis (primarily by polysomnography), use of polygraphic methods, analysis of polysomnography (PSG), indications for positive airway pressure (PAP) therapy, application of standard continuous PAP (CPAP) therapy (100% with an CPAP/APAP ratio of 2.24:1), and the need (90.5%) and management of follow-up. Differences were apparent in reimbursement of the diagnostic procedures and follow-up, in the procedures for PAP titration from home APAP titration with portable sleep apnea monitoring (38.1%) up to hospital monitoring with PSG and APAP (85.7%), and in the qualification requirements of sleep physicians. Conclusions: Management of OSA in different European countries is similar except for reimbursement rules, qualification of sleep specialists and procedures for titration of the CPAP treatment. A European network (such as the one accomplished by the European Cooperation in Science and Technology [COST] B26 Action) could be helpful for implementing these findings into health-service research in order to standardize management in a cost effective perspective.",

author = "I Fietze and T Penzel and A Alonderis and F Barbe and Bonsignore, {M R} and P Calverly and {De Backer}, W and K Diefenbach and V Donic and Eijsvogel, {M M} and Franklin, {K A} and T Gislason and L Grote and J Hedner and Jennum, {Poul J{\o}rgen} and L Lavie and P Lavie and Paul Levy and C Lombardi and W Mallin and O Marrone and Montserrat Anguita and Papathanasiou, {E S} and G Parati and R Plywaczewski and M Pretl and Riha, {R L} and D Rodenstein and T Saaresranta and R Schulz and P Sliwinski and P Steiropoulos and J Svaza and Z Tomori and Philip T{\o}nnesen and G Varoneckas and J Verbraecken and J Vesely and A Vitols and J Zielinski and McNicholas, {W T} and Poul Jennum",

year = "2011",

month = feb,

day = "1",

doi = "10.1016/j.sleep.2010.10.003",

language = "English",

volume = "12",

pages = "190--7",

journal = "Sleep Medicine",

issn = "1389-9457",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Management of obstructive sleep apnea in Europe

AU - Fietze, I

AU - Penzel, T

AU - Alonderis, A

AU - Barbe, F

AU - Bonsignore, M R

AU - Calverly, P

AU - De Backer, W

AU - Diefenbach, K

AU - Donic, V

AU - Eijsvogel, M M

AU - Franklin, K A

AU - Gislason, T

AU - Grote, L

AU - Hedner, J

AU - Jennum, Poul Jørgen

AU - Lavie, L

AU - Lavie, P

AU - Levy, Paul

AU - Lombardi, C

AU - Mallin, W

AU - Marrone, O

AU - Anguita, Montserrat

AU - Papathanasiou, E S

AU - Parati, G

AU - Plywaczewski, R

AU - Pretl, M

AU - Riha, R L

AU - Rodenstein, D

AU - Saaresranta, T

AU - Schulz, R

AU - Sliwinski, P

AU - Steiropoulos, P

AU - Svaza, J

AU - Tomori, Z

AU - Tønnesen, Philip

AU - Varoneckas, G

AU - Verbraecken, J

AU - Vesely, J

AU - Vitols, A

AU - Zielinski, J

AU - McNicholas, W T

AU - COST Action B26 Group

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services. Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example. Results: Sleep centers from 21 countries (38 physicians) participated. A broad consistency among countries with respect to the following was found: pathways included referral to sleep physicians/sleep laboratories, necessity for objective diagnosis (primarily by polysomnography), use of polygraphic methods, analysis of polysomnography (PSG), indications for positive airway pressure (PAP) therapy, application of standard continuous PAP (CPAP) therapy (100% with an CPAP/APAP ratio of 2.24:1), and the need (90.5%) and management of follow-up. Differences were apparent in reimbursement of the diagnostic procedures and follow-up, in the procedures for PAP titration from home APAP titration with portable sleep apnea monitoring (38.1%) up to hospital monitoring with PSG and APAP (85.7%), and in the qualification requirements of sleep physicians. Conclusions: Management of OSA in different European countries is similar except for reimbursement rules, qualification of sleep specialists and procedures for titration of the CPAP treatment. A European network (such as the one accomplished by the European Cooperation in Science and Technology [COST] B26 Action) could be helpful for implementing these findings into health-service research in order to standardize management in a cost effective perspective.

AB - Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services. Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example. Results: Sleep centers from 21 countries (38 physicians) participated. A broad consistency among countries with respect to the following was found: pathways included referral to sleep physicians/sleep laboratories, necessity for objective diagnosis (primarily by polysomnography), use of polygraphic methods, analysis of polysomnography (PSG), indications for positive airway pressure (PAP) therapy, application of standard continuous PAP (CPAP) therapy (100% with an CPAP/APAP ratio of 2.24:1), and the need (90.5%) and management of follow-up. Differences were apparent in reimbursement of the diagnostic procedures and follow-up, in the procedures for PAP titration from home APAP titration with portable sleep apnea monitoring (38.1%) up to hospital monitoring with PSG and APAP (85.7%), and in the qualification requirements of sleep physicians. Conclusions: Management of OSA in different European countries is similar except for reimbursement rules, qualification of sleep specialists and procedures for titration of the CPAP treatment. A European network (such as the one accomplished by the European Cooperation in Science and Technology [COST] B26 Action) could be helpful for implementing these findings into health-service research in order to standardize management in a cost effective perspective.

U2 - 10.1016/j.sleep.2010.10.003

DO - 10.1016/j.sleep.2010.10.003

M3 - Journal article

SN - 1389-9457

VL - 12

SP - 190

EP - 197

JO - Sleep Medicine

JF - Sleep Medicine

IS - 2

ER -

Management of obstructive sleep apnea in Europe

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater